Dark Forest Capital Management LP Castle Biosciences Inc Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $147,958 - $225,585	6,573 New	6,573 $171,000
Q1 2022 May 13, 2022	SELL	$33.17 - $46.98 $2,885 - $4,087	-87 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$39.06 - $67.58 $376,538 - $651,471	-9,640 Reduced 99.11%	87 $4,000
Q3 2021 Nov 12, 2021	BUY	$60.13 - $77.6 $370,040 - $477,550	6,154 Added 172.24%	9,727 $647,000
Q2 2021 Aug 16, 2021	BUY	$50.07 - $76.78 $178,900 - $274,334	3,573 New	3,573 $262,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.